Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years

Front Pharmacol. 2022 Apr 12:13:896418. doi: 10.3389/fphar.2022.896418. eCollection 2022.

Xiao-Ming He^{1

2}, Min-Cong He^{1

2}, Peng Yang^{1

2}, Qing-Wen Zhang^{1

2}, Zhen-Qiu Chen³, Wei He^{1

2}, Qiu-Shi Wei^{1

2}

¹ Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.
² Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
³ The Third Orthopaedic Region, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.773758.].

Keywords: ARCO stage II; huo xue tong luo; osteonecrosis of femoral head; risk factor; therapeutic effect.